Form D · Biotechnology
Advantagene, Inc.
Auburndale, MA · CIK 0001660549
Offering snapshot reported Nov 26, 2018 · SEC filing
- Reported sold
- $28.7M Offering amount: $28.7M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 13, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 26, 2018 | Initial | $28,703,591 | No comparison | 18 | SEC filing |
| Sep 14, 2016 | Amendment | $14,171,427 | $1,283,504vs Jul 13, 2016 | 251 | SEC filing |
| Jul 13, 2016 | Amendment | $12,887,923 | $7,863,994vs Apr 20, 2016 | 230 | SEC filing |
| Jun 13, 2016 | Amendment | $9,957,971 | $1,280,865vs May 16, 2016 | 191 | SEC filing |
| May 16, 2016 | Amendment | $8,677,106 | $3,653,177vs Apr 20, 2016 | 166 | SEC filing |
| Apr 20, 2016 | Initial | $5,023,929 | No comparison | 108 | SEC filing |
| Dec 21, 2015 | Initial | $2,200,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326482
Amount sold in item 13 includes $3,703,470 from conversion of promissory notes.
Source: Form D, filed Nov 26, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laura Aguilar | Executive |
| Estuardo Aguilar Cordova | Director, Executive |
| Edward J. Benz | Director |
| Mitchell Finer | Director |
| Paul Manning | Director |
| Chris Martell | Director |
| Glenn Mattes | Director |
| Udi Merav | Director |
| Fred Mermelstein | Director |
| Stephen C. Rocamboli | Executive |
| Alan Smith | Director |
| Sean Stalfort | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
440 Lexington Street
Auburndale, MA, 02466
Auburndale, MA, 02466